Citation: | HE Cheng-cheng, JIN Guo-xi, BI Ya-xin. Expression of B cell activating factor and interleukin-21 in the plasma of patients with Hashimoto's thyroiditis[J]. Chinese Journal of General Practice, 2021, 19(4): 568-571. doi: 10.16766/j.cnki.issn.1674-4152.001863 |
[1] |
方露, 朱武飞, 廖翔宇, 等. 桥本氏甲状腺炎患者年龄、性别分布及自身免疫抗体水平分析[J]. 微循环学杂志, 2020, 30(1): 69-72. doi: 10.3969/j.issn.1005-1740.2020.01.015
|
[2] |
王薇, 卢桂芝, 高燕明, 等. 甲状腺针吸细胞学检查的不同年龄段患者临床特点分析[J]. 中华全科医学, 2019, 17(5): 738-741. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201905010.htm
|
[3] |
LUTY J, RUCKEMANN-DZIURDZINSKA K, WITKOWSKI J M, et al. Immunological aspects of autoimmune thyroid disease-Complex interplay between cells and cytokines[J]. Cytokine, 2019, 116: 128-133. doi: 10.1016/j.cyto.2019.01.003
|
[4] |
詹玲, 陈创, 孙圣荣. 免疫微环境在桥本甲状腺炎与甲状腺癌中作用研究进展[J]. 中华实用诊断与治疗杂志, 2020, 34(6): 640-642. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD202006027.htm
|
[5] |
ROBINSON M J, PITT C, BRODIE E J, et al. BAFF, IL-4 and IL-21 separably program germinal center-like phenotype acquisition, BCL6 expression, proliferation and survival of CD40L-activated B cells in vitro[J]. Immunol Cell Biol, 2019, 97(9): 826-839. doi: 10.1111/imcb.12283
|
[6] |
ZHAO R Q, ZHANG H H, ZHANG Y, et al. In vivo screen identifies Zdhhc2 as a critical regulator of germinal center B cell differentiation[J]. Front Immunol, 2020, 11: 1025. doi: 10.3389/fimmu.2020.01025
|
[7] |
NAKAYAMA Y, KOSEK J, CAPONE L, et al. Aiolos overexpression in systemic lupus erythematosus B Cell subtypes and BAFF-induced memory B cell differentiation are reduced by CC-220 modulation of cereblon activity[J]. J Immunol, 2017, 199(7): 2388-2407. doi: 10.4049/jimmunol.1601725
|
[8] |
GHARIBI T, HOSSEINI A, MAROFI F, et al. IL-21 and IL-21-producing T cells are involved in multiple sclerosis severity and progression[J]. Immunol Lett, 2019, 216: 12-20. doi: 10.1016/j.imlet.2019.09.003
|
[9] |
DINESH P, RASOOL M. Multifaceted role of IL-21 in rheumatoid arthritis: Current understanding and future perspectives[J]. J Cell Physiol, 2018, 233(5): 3918-3928. doi: 10.1002/jcp.26158
|
[10] |
ZHOU H, HU B, ZHAOPENG Z, et al. Elevated circulating T cell subsets and cytokines expression in patients with rheumatoid arthritis[J]. Clin Rheumatol, 2019, 38(7): 1831-1839. doi: 10.1007/s10067-019-04465-w
|
[11] |
GENSOUS N, SCHMITT N, RICHEZ C, et al. T follicular helper cells, interleukin-21 and systemic lupus erythematosus[J]. Rheumatology(Oxford), 2017, 56(4): 516-523.
|
[12] |
CHENG C W, TANG K T, FANG W F, et al. Synchronized expressions of serum osteopontin and B cell-activating factor in autoimmune thyroid disease[J]. Eur J Clin Invest, 2019, 49(7): e13122. http://www.ncbi.nlm.nih.gov/pubmed/31034586
|
[13] |
CHENG C W, WU C Z, TANG K T, et al. Simultaneous measurement of twenty-nine circulating cytokines and growth factors in female patients with overt autoimmune thyroid diseases[J]. Autoimmunity, 2020, 53(5): 261-269. doi: 10.1080/08916934.2020.1755965
|
[14] |
FENG Y, QIU T, CHEN H, et al. Association of serum IL-21 and vitamin D concentrations in Chinese children with autoimmune thyroid disease[J]. Clin Chim Acta, 2020, 507: 194-198. doi: 10.1016/j.cca.2020.04.030
|
[15] |
RAMOS-LEVI A M, MARAZUELA M. Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms[J]. Endocrinol Nutr, 2016, 63(8): 421-429. doi: 10.1016/j.endonu.2016.04.003
|
[16] |
RYDZEWSKA M, JAROMIN M, PASIEROWSKA I E, et al. Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases[J]. Thyroid Res, 2018, 11: 2. doi: 10.1186/s13044-018-0046-9
|
[17] |
MAO J N, SHEN Y S, LUO X Y, et al. Expression of IL-21 in rats with inflammatory bowel disease[J]. Genet Mol Res, 2015, 14(4): 17322-17328. doi: 10.4238/2015.December.16.33
|
[18] |
CARRILLO-BALLESTEROS F J, PALAFOX-SANCHEZ C A, FRANCO-TOPETE R A, et al. Expression of BAFF and BAFF receptors in primary Sjogren's syndrome patients with ectopic germinal center-like structures[J]. Clin Exp Med, 2020, 20(4): 615-626. doi: 10.1007/s10238-020-00637-0
|
[19] |
VINCENT F B, KANDANE-RATHNAYAKE R, KOELMEYER R, et al. Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus[J]. Lupus Sci Med, 2020, 7(1): e000375. doi: 10.1136/lupus-2019-000375
|
[20] |
CAMPI I, TOSI D, ROSSI S, et al. B Cell Activating Factor (BAFF) and BAFF receptor expression in autoimmune and nonautoimmune thyroid diseases[J]. Thyroid, 2015, 25(9): 1043-1049. doi: 10.1089/thy.2015.0029
|
[21] |
CHENG C W, WU C Z, TANG K T, et al. Simultaneous measurement of twenty-nine circulating cytokines and growth factors in female patients with overt autoimmune thyroid diseases[J]. Autoimmunity, 2020, 53(5): 261-269. doi: 10.1080/08916934.2020.1755965
|